Related Experiment Video
Updated: Sep 20, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Composition and Function of the Gut Microbiome in Microscopic Colitis
Background:
Microscopic colitis (MC) is a common cause of chronic diarrhea, predominantly among older adults. Emerging evidence suggests that perturbations of gut microbiome and metabolome may play an important role in MC pathogenesis.
Objective:
To comprehensively characterize alterations of the gut microbial and metabolic composition in MC.
Design:
We established a longitudinal cohort of adult patients with MC and two control groups of individuals - chronic diarrhea controls and age- and sex-matched controls without diarrhea. Using stool samples, gut microbiome was analyzed by whole-genome shotgun metagenomic sequencing, and gut metabolome was profiled by ultra-high performance liquid chromatography-mass spectrometry. Per-feature enrichment analyses of microbial species, metabolic pathways, and metabolites were done using multivariable linear models both cross-sectionally comparing MC to controls and longitudinally according to disease activity. Lastly, we performed multi-omics association analyses to assess the relationship between microbiome and metabolome data.
Results:
We included 683 participants, 131 with active MC (66 with both active and remission samples), 159 with chronic diarrhea, and 393 age- and sex-matched controls without diarrhea. The stool microbiome in active MC was characterized by a lower alpha diversity as compared to controls and the remission phase of MC. Compared to controls, we identified eight enriched species in MC, most of which were pro-inflammatory oral-typical species, such as Veillonella dispar and Haemophilus parainfluenzae . In contrast, 11 species, including anti-inflammatory microbes such as Blautia glucerasea and Bacteroides stercoris, were depleted in MC. Similarly, pro-inflammatory metabolites, including lactosylceramides, ceramides, lysophospholipids, and lysoplasmalogens were enriched in active MC as compared to controls or MC cases in remission. Multi-omics association analyses revealed strong and concordant links between microbes, their metabolic pathways, and metabolomic profiles, supporting the tight interplay between disturbances in stool microbiome and metabolome in MC.
Conclusion:
We observed a significant shift in stool microbial and metabolomic composition in MC. Our findings could be used in the future for development of non-invasive biomarkers for diagnosing and monitoring MC and developing novel therapeutics.
What Is Already Known On This Topic:
Microbiome dysbiosis has been proposed to contribute to microscopic colitis (MC) pathogenesis.However, previous studies have been limited by small sample sizes, reliance on 16S rRNA sequencing technique, potential confounding by stool consistency, and lack of functional analyses of microbiome and longitudinal data. Moreover, the metabolomic composition of MC remain largely unknown.
What This Study Adds:
In this largest longitudinal MC cohort with two control groups - chronic diarrhea controls and controls without diarrhea, gut microbiome of MC is characterized by a lower alpha diversity, enriched pro-inflammatory oral-typical species and depleted anti-inflammatory beneficial species.Gut metabolome of MC shows significant enrichment of pro-inflammatory metabolites, including lactosylceramides, ceramides, lysophospholipids, and lysoplasmalogens. Multi-omics analyses demonstrate strong and concordant relationships between microbes, metabolic pathways, and metabolomic profiles.
How This Study Might Affect Research Practice Or Policy:
Our findings could facilitate development of non-invasive biomarkers and novel therapeutics for MC.
Insights
Microscopic colitis (MC) involves gut microbiome and metabolome shifts, with pro-inflammatory microbes and metabolites enriched. This research offers potential for new diagnostic biomarkers and therapies for MC.
Area of Science:
- Gastroenterology and Gut Microbiome Research
- Metabolomics and Multi-omics Analysis
- Inflammatory Bowel Disease Pathogenesis
Background:
- Microscopic colitis (MC) is a frequent cause of chronic diarrhea, particularly in older individuals.
- Gut microbiome and metabolome alterations are increasingly implicated in MC development.
- Previous research was limited by sample size and methodology.
Purpose of the Study:
- To comprehensively characterize gut microbial and metabolic alterations in microscopic colitis.
- To investigate the relationship between microbiome and metabolome in MC.
- To identify potential biomarkers for MC diagnosis and treatment.
Main Methods:
- Longitudinal cohort study with MC patients and two control groups.
- Whole-genome shotgun metagenomic sequencing for microbiome analysis.
- Ultra-high performance liquid chromatography-mass spectrometry for metabolome profiling.
- Multi-omics association analyses to link microbial and metabolic data.
Main Results:
- Active MC showed lower gut microbial alpha diversity compared to controls and remission phases.
- Enriched pro-inflammatory species (e.g., Veillonella dispar) and depleted anti-inflammatory species (e.g., Blautia glucerasea) were observed in MC.
- Pro-inflammatory metabolites (e.g., lactosylceramides, ceramides) were significantly enriched in active MC.
- Strong associations were found between specific microbes, their pathways, and metabolomic profiles.
Conclusions:
- Significant shifts in gut microbial and metabolomic composition characterize microscopic colitis.
- Findings support the interplay between microbiome and metabolome dysbiosis in MC pathogenesis.
- This study provides a foundation for developing non-invasive MC biomarkers and novel therapeutics.
Related Concept Videos
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Histology of the Small Intestine
The intestinal lining features transverse folds called circular folds, each housing fingerlike projections known as intestinal villi. These villi are covered by a layer of simple columnar epithelium, also referred to as...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

